340B Software
1 view | +0 today
Follow
Your new post is loading...
Your new post is loading...
Rescooped by Eugene Joy from Pharma & Medical Devices
Scoop.it!

Drug Industry Says 340B Discount Program Is Being Abused

Drug Industry Says 340B Discount Program Is Being Abused | 340B Software | Scoop.it
Drug makers say a system of discounts intended for low-income and uninsured patients is being abused, but hospitals say they can’t do business without it.

Via Richard Meyer
more...
No comment yet.
Rescooped by Eugene Joy from Breast Cancer Advocacy
Scoop.it!

340B Drug Discount Program Draws Scrutiny

340B Drug Discount Program Draws Scrutiny | 340B Software | Scoop.it

"For years, the 340B Drug Discount Program has been a source of pride for some oncologists, a source of envy for others, and a source of confusion for those of us who wondered what it was all about.


But now that the fast-growing program is creating a haves-vs.-have nots differential between oncology practices, I suspect we are going to be learning a lot more about exactly how this works. The 340B program allows some hospitals -- and, importantly, hospital-affiliated practices -- to buy drugs at deep discounts, ostensibly to help offset their costs for treating poor patients. The program started out small but that didn’t last; a Government Accounting Office report found that the number of hospital participating increased from 591 in 2005 to 1,673 in 2011, by which time nearly one-third of all hospitals in the country were eligible for the discounts.".


Via Susan Zager
more...
Susan Zager's curator insight, April 30, 2013 4:48 PM
The article states:

Rena Conti, PhD, published a Viewpoint article in the Journal of the American Medical Association, saying that the 340B program may actually be increasing the costs of patient care, because, among things, it encourages private oncology practices to affiliate with 340B-eligible hospitals -- and hospitals are reimbursed for drug administration at higher rates than independent practices.


Now the benefits of the 340B program discounts mostly go entirely to manufacturers of the medications. The financial burden burden "will end up accruing almost entirely to hospitals, clinics, and physicians; and patients’ out-of-pocket costs and total cost of care are being increased.”


Here's just another example of when it comes to our costs for oncological care, we will pay the price. This also is another example of how difficult it is getting for small oncology practices to keep their doors open to patients.

Scooped by Eugene Joy
Scoop.it!

340B Drug Pricing Program Developments InTthe New Year - Mondaq News Alerts (registration)

340B Drug Pricing Program Developments InTthe New Year - Mondaq News Alerts (registration) | 340B Software | Scoop.it
340B Drug Pricing Program Developments InTthe New Year Mondaq News Alerts (registration) On January 9, 2014, the Health Resources and Services Administration (HRSA) posted an update on its current and anticipated 340B drug pricing program (340B)...
more...
No comment yet.